Elastin fragments induce IL-1β upregulation via NF-κB pathway in melanoma cells

Journal of Investigative Dermatology

Volumn 126, Issue 8, 2006, Pages 1860-1868

  Debret, Romain ^a   Le Naour, Richard R ^a   Sallenave, Jean Michel ^b   Deshorgue, Aurelie ^a   Hornebeck, William G ^a   Guenounou, Moncef ^a   Bernard, Philippe ^a   Antonicelli, Frank D ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ELASTIN; GALACTOSIDASE; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; LACTOSE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; PEPTIDE; SN 50; UNCLASSIFIED DRUG; VALYLGLYCYLVALYLALANYLPROLYLGLYCINE PEPTIDE;

ANALYTIC METHOD; ANIMAL MODEL; ARTICLE; CARCINOGENIC ACTIVITY; CELL ACTIVATION; CELL STIMULATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MELANOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN TRANSPORT; UPREGULATION;

BASE SEQUENCE; ELASTIN; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTERLEUKIN-1; MAP KINASE SIGNALING SYSTEM; MELANOMA; NF-KAPPA B P50 SUBUNIT; PEPTIDE FRAGMENTS; PROMOTER REGIONS (GENETICS); RECEPTORS, INTERLEUKIN-1; SKIN NEOPLASMS; TRANSCRIPTION FACTOR RELA; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 33746142007     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5700337     Document Type: Article

References (44)

1. Antonicelli F, Brown D, Parmentier M, Drost EM, Hirani N, Rahman I et al. (2004) Regulation of LPS-mediated inflammation in vivo and in vitro by the thiol antioxidant Nacystelyn. Am J Physiol Lung Cell Mol Physiol 286:L1319-27
2. Berthier-Vergnes O, Portoukalian J, Dore JF (1985) Expression of cell surface glycoproteins in human melanoma cell lines with different tumorigenic properties. Int J Cancer 36:461-6
3. Bjorkdahl O, Dohlsten M, Sjogren HO (2000) Vaccination with B16 melanoma cells expressing a secreted form of interleukin-1beta induces tumor growth inhibition and an enhanced immunity against the wild-type B16 tumor. Cancer Gene Ther 7:1365-74
4. Blood CH, Sasse J, Brodt P, Zetter BR (1988) Identification of a tumor cell receptor for VGVAPG, an elastin-derived chemotactic peptide. J Cell Biol 107:1987-93
5. Debret R, Antonicelli F, Theill A, Hornebeck W, Bernard P, Guenounou M et al. (2005) Elastin-derived peptides induce a T-helper type 1 polarization of human blood lymphocytes. Arterioscler Thromb Vasc Biol 25:1353-8
6. Dhawan P, Richmond A (2002) Role of CXCL1 in tumorigenesis of melanoma. J Leukoc Biol 72:9-18
7. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87:2095-147
8. Duca L, Debelle L, Debret R, Antonicelli F, Hornebeck W, Haye B (2002) The elastin peptides-mediated induction of pro-collagenase-1 production by human fibroblasts involves activation of MEK/ERK pathway via PKA- and PI(3)K-dependent signaling. FEBS Lett 524:193-8
9. Duca L, Floquet N, Alix AJ, Haye B, Debelle L (2004) Elastin as a matrikine. Crit Rev Oncol Hematol 49:235-44
10. Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E (1990a) Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50:7820-5
11. Gansbacher B, Zier K, Daniels B, Cronin K, Bannerji R, Gilboa E (1990b) Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity. J Exp Med 172:1217-24
12. Goto M, Katayama KI, Shirakawa F, Tanaka I (1999) Involvement of NF-kappaB p50/p65 heterodimer in activation of the human pro-interleukin-1beta gene at two subregions of the upstream enhancer element. Cytokine 11:16-28
13. Graham F, Prevec L (1991) Manipulation of adenovirus vectors. In: Methods In Molecular Biology. (Murray E, ed), Humana Press: Clifton, NJ, USA pp 109-28
14. Henriksen PA, Hitt M, Xing Z, Wang J, Haslett C, Riemersma RA et al. (2004) Adenoviral gene delivery of elafin and secretory leukocyte protease inhibitor attenuates NF-kappa B-dependent inflammatory responses of human endothelial cells and macrophages to atherogenic stimuli. J Immunol 172:4535-44
15. Hinek A (1996) Biological roles of the non-integrin elastin/laminin receptor. Biol Chem 377:471-80
16. Hinek A, Wrenn DS, Mecham RP, Barondes SH (1988) The elastin receptor: a galactoside-binding protein. Science 239:1539-41
17. Hiscott J, Marois J, Garoufalis J, D'Addario M, Roulston A, Kwan I et al. (1993) Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop. Mol Cell Biol 13:6231-40
18. Hofmann UB, Houben R, Brocker EB, Becker JC (2005) Role of matrix metalloproteinases in melanoma cell invasion. Biochimie 87:307-14
19. Hornebeck W, Emonard H, Monboisse JC, Bellon G (2002) Matrix-directed regulation of pericellular proteolysis and tumor progression. Semin Cancer Biol 12:231-41
20. Jobin C, Haskill S, Mayer L, Panja A, Sartor RB (1997) Evidence for altered regulation of I kappa B alpha degradation in human colonic epithelial cells. J Immunol 158:226-34
21. Karin M (2005) Inflammation and cancer: the long reach of Ras. Nat Med 11:20-1
22. Kunsch C, Ruben SM, Rosen CA (1992) Selection of optimal kappa B/Rel DNA-binding motifs: interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol Cell Biol 12:4412-21
23. Lai JH, Horvath G, Subleski J, Bruder J, Ghosh P, Tan TH (1995) RelA is a potent transcriptional activator of the CD28 response element within the interleukin 2 promoter. Mol Cell Biol 15:4260-71
24. Lazar-Molnar E, Hegyesi H, Toth S, Falus A (2000) Autocrine and paracrine regulation by cytokines and growth factors in melanoma. Cytokine 12:547-54
25. Lin YZ, Yao SY, Veach RA, Torgerson TR, Hawiger J (1995) Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence. J Biol Chem 270:14255-8
26. Loffek S, Zigrino P, Angel P, Anwald B, Krieg T, Mauch C (2005) High invasive melanoma cells induce matrix metalloproteinase-1 synthesis in fibroblasts by interleukin-1 alpha and basic fibroblast growth factor-mediated mechanisms. J Invest Dermatol 124:638-43
27. Maquart FX, Bellon C, Pasco S, Monboisse JC (2005) Matrikines in the regulation of extracellular matrix degradation. Biochimie 87:353-60
28. Mecham RP, Hinek A, Griffin GL, Senior RM, Liotta LA (1989) The elastin receptor shows structural and functional similarities to the 67-kDa tumor cell laminin receptor. J Biol Chem 264:16652-7
29. Menasche M, Jacob MP, Godeau G, Robert AM, Robert L (1981) Pharmacological studies on elastin peptides (kappa-elastin). Blood clearance, percutaneous penetration and tissue distribution. Pathol Biol (Paris) 29:548-54
30. Mochizuki S, Brassart B, Hinek A (2002) Signaling pathways transduced through the elastin receptor facilitate proliferation of arterial smooth muscle cells. J Biol Chem 277:44854-63
31. Ntayi C, Labrousse AL, Debret R, Birembaut P, Bellon G, Antonicelli F et al. (2004) Elastin-derived peptides upregulate matrix metalloproteinase-2- mediated melanoma cell invasion through elastin-binding protein. J Invest Dermatol 122:256-65
32. Privitera S, Prody CA, Callahan JW, Hinek A (1998) The 67-kDa enzymatically inactive alternatively spliced variant of beta-galactosidase is identical to the elastin/laminin-binding protein. J Biol Chem 273:6319-26
33. Robinet A, Fahem A, Cauchard JH, Huet E, Vincent L, Lorimier S et al. (2005) Elastin-derived peptides enhance angiogenesis by promoting endothelial cell migration and tubulogenesis through upregulation of MT1-MMP. J Cell Sci 118:343-56
34. Roman J, Ritzenthaler JD, Perez RL, Roser SL (1999) Differential modes of regulation of interleukin-1beta expression by extracellular matrices. Immunology 98:228-37
35. Shattuck RL, Wood LD, Jaffe GJ, Richmond A (1994) MGSA/GRO transcription is differentially regulated in normal retinal pigment epithelial and melanoma cells. Mol Cell Biol 14:791-802
36. Vermeulen L, De Wilde G, Van Damme P, Vanden Berghe W, Haegeman G (2003) Transcriptional activation of the NF-kappaB p65 subunit by mitogen-and stress-activated protein kinase-1 (MSK1). EMBO J 22:1313-24
37. Vidal-Vanaclocha F, Alvarez A, Asumendi A, Urcelay B, Tonino P, Dinarello CA (1996) Interleukin 1 (IL-1)-dependent melanoma hepatic metastasis in vivo; increased endothelial adherence by IL-1-induced mannose receptors and growth factor production in vitro. J Natl Cancer Inst 88: 198-205
38. Voronov E, Shouval DS, Krelin Y, Cagnano E, Benharroch D, Iwakura Y et al. (2003) IL-1 is required for tumor invasiveness and angiogenesis. Proc Natl Acad Sci USA 100:2645-50
39. Wood LD, Richmond A (1995) Constitutive and cytokine-induced expression of the melanoma growth stimulatory activity/GRO alpha gene requires both NF-kappa B and novel constitutive factors. J Biol Chem 270:30619-26
40. Xie Z, Singh M, Singh K (2004) Differential regulation of matrix metalloproteinase-2 and -9 expression and activity in adult rat cardiac fibroblasts in response to interleukin-1beta. J Biol Chem 279:39513-9
41. Xie Z, Singh M, Siwik DA, Joyner WL, Singh K (2003) Osteopontin inhibits interleukin-1beta-stimulated increases in matrix metalloproteinase activity in adult rat cardiac fibroblasts: role of protein kinase C-zeta. J Biol Chem 278:48546-52
42. Yamamoto M, Akazawa K, Aoyagi M, Yamamoto N, Yamamoto K (2002) Changes in elastin-binding protein in fibroblasts derived from cardinal ligaments of patients with prolapsus uteri. Cell Biol Int 26:441-9
43. Yano S, Nokihara H, Yamamoto A, Goto H, Ogawa H, Kanematsu T et al. (2003) Multifunctional interleukin-1beta promotes metastasis of human lung cancer cells in SCID mice via enhanced expression of adhesion-, invasion- and angiogenesis-related molecules. Cancer Sci 94:244-52
44. Zhong H, SuYang H, Erdjument-Bromage H, Tempst P, Ghosh S (1997) The transcriptional activity of NF-kappaB is regulated by the IkappaB-associated PKAc subunit through a cyclic AMP-independent mechanism. Cell 89:413-24